Century Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Century Therapeutics, Inc. (Nasdaq: IPSC), an emerging growth company incorporated in Delaware. The report covers events occurring on December 18, 2025, with the filing signed on December 29, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On December 18, 2025, Carlo Rizzuto, Ph.D., resigned from the Board of Directors, effective immediately. The Company stated that Dr. Rizzuto's departure was not the result of any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary on future guidance, outlook, or specific risks. The Company expressed gratitude for Dr. Rizzuto's distinguished service and contributions. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the composition of the Board of Directors following Dr. Rizzuto's resignation.
- Confirm whether a successor director has been appointed or if a vacancy remains.
- Review recent 10-K or 10-Q filings for the most current financial position, as this 8-K contains no financial data.